Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tetsushi Sadakata, Miwa Washida, Yoshimi Iwayama, Satoshi Shoji, Yumi Sato, Takeshi Ohkura, Ritsuko Katoh-Semba, Mizuho Nakajima, Yukiko Sekine, Mika Tanaka, Kazuhiko Nakamura, Yasuhide Iwata, Kenji J. Tsuchiya, Norio Mori, Sevilla D. Detera-Wadleigh, Hironobu Ichikawa, Shigeyoshi Itohara, Takeo Yoshikawa, Teiichi Furuichi
Published in Volume 117, Issue 4
J Clin Invest. 2007; 117(4):931–943 doi:10.1172/JCI29031
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
Aberrant CADPS2 splicing in autistic patients.

(A and B) RT-PCR analysis of CADPS2 mRNA in blood from autistic patients (a1–a16) (A) and healthy control subjects (c1–c24) (B). A single major band (661 bp) is apparent in the control individuals. An additional band (381 bp) that resulted from skipping of exon 3 was detected in patients a2, a4, a5, and a13. The primers used are indicated on the corresponding exons by arrows. M, 100-bp ladder molecular size marker (from 200 bp at the bottom to 1000 bp at the top). (C) Sequencing pattern of the aberrant RT-PCR product from patient a4. The arrows indicate exon 2–exon 4 in the frame without exon 3. The same results were obtained in 3 other patients (a2, a5, and a13).